cohort_44835_female

http://metadb.riken.jp/db/IMPC_RDF/Cohort/44835_female

cohort_44835_female

解析コホート

性別

http://metadb.riken.jp/db/bioresource_schema/brs_sexForGrouping

• female
  http://purl.obolibrary.org/obo/PATO_0000383

遺伝子型

http://metadb.riken.jp/db/bioresource_schema/brs_groupingGenotype

• Peli1<tm1b(EUCOMM)Wtsi>/Peli1<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/IMPC_RDF/Genotype/Peli1_tm1b(EUCOMM)Wtsi-Peli1_tm1b(EUCOMM)Wtsi

アレル

http://metadb.riken.jp/db/bioresource_schema/brs_groupingAllele

• Peli1<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5548537

遺伝的背景

http://metadb.riken.jp/db/bioresource_schema/brs_groupingGenticBackground

• http://metadb.riken.jp/db/mgi_rdf/MGI:2683688

コロニーID

http://metadb.riken.jp/db/bioresource_schema/brs_groupingColony

• http://metadb.riken.jp/db/IMPC_RDF/Colony/BL3735

マウス数

http://metadb.riken.jp/db/bioresource_schema/brs_numberOfMember

• 0

アレル

http://www.w3.org/2000/01/rdf-schema#seeAlso

親コホート

http://purl.obolibrary.org/obo/BFO_0000050

• cohort_44835
  http://metadb.riken.jp/db/IMPC_RDF/Cohort/44835

表現型アノテーション

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesWholeEntity

• IMPC_phenotype_call_63306:decreased circulating insulin level
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/63306
• IMPC_phenotype_call_54536:decreased total body fat amount
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54536
• IMPC_phenotype_call_58227:decreased circulating serum albumin level
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/58227
• IMPC_phenotype_call_70828:decreased startle reflex
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/70828
• IMPC_phenotype_call_55681:improved glucose tolerance
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/55681
• IMPC_phenotype_call_54534:increased lean body mass
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54534
• IMPC_phenotype_call_54530:decreased bone mineral content
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54530
• IMPC_phenotype_call_58235:decreased circulating triglyceride level
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/58235
• IMPC_phenotype_call_54532:decreased body length
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54532
• IMPC_phenotype_call_54526:decreased lean body mass
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54526
• IMPC_phenotype_call_54538:abnormal bone structure
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54538
• IMPC_phenotype_call_54528:decreased bone mineral density
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54528
• IMPC_phenotype_call_58233:decreased circulating cholesterol level
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/58233
• IMPC_phenotype_call_58229:decreased circulating bilirubin level
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/58229
• IMPC_phenotype_call_46750:enlarged spleen
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/46750
• IMPC_phenotype_call_46749:abnormal spleen morphology
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/46749
• IMPC_phenotype_call_54524:decreased total body fat amount
  http://metadb.riken.jp/db/IMPC_RDF/Phenotype_summary/54524